Fiera Capital Corp Abb Vie Inc. Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

A detailed history of Fiera Capital Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiera Capital Corp holds 59,628 shares of ABBV stock, worth $10.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

59,628

Previous 56,187 6.12%

Holding current value

$10.5 Million

Previous $9.64 Million 22.19%

% of portfolio

0.04%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$163.84 - $199.33 $563,773 - $685,894	3,441 Added 6.12%	59,628 $11.8 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $8.22 Million - $9.6 Million	53,112 Added 1727.22%	56,187 $9.64 Million
Q1 2024 Aug 22, 2024	SELL	$159.82 - $182.1 $8.49 Million - $9.67 Million	-53,112 Reduced 94.53%	3,075 $559,000
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $34,361 - $39,151	-215 Reduced 6.53%	3,075 $559,000
Q4 2023 Aug 22, 2024	SELL	$137.6 - $154.97 $27,520 - $30,994	-200 Reduced 5.73%	3,290 $509,000
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $27,520 - $30,994	-200 Reduced 5.73%	3,290 $509,000
Q3 2023 Aug 22, 2024	SELL	$133.59 - $154.65 $7.04 Million - $8.15 Million	-52,697 Reduced 93.79%	3,490 $520,000
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $12,023 - $13,918	90 Added 2.65%	3,490 $520,000
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $450,533 - $560,660	3,400 New	3,400 $458,000
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $1.48 Million - $1.7 Million	11,027 Added 299.73%	14,706 $1.97 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $1.76 Million - $2.24 Million	-12,800 Reduced 77.67%	3,679 $563,000
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $1.4 Million - $1.74 Million	10,628 Added 181.64%	16,479 $2.67 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $51,458 - $65,110	479 Added 8.92%	5,851 $792,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.43 Million - $1.62 Million	-13,431 Reduced 71.43%	5,372 $579,000
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $1.98 Million - $2.2 Million	18,803 New	18,803 $1.85 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $2.77 Million - $3.05 Million	-27,074 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $2,012 - $2,716	25 Added 0.09%	27,074 $2.9 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $985,903 - $1.16 Million	-11,476 Reduced 29.79%	27,049 $2.37 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $14,380 - $19,243	-196 Reduced 0.51%	38,525 $3.78 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $204,594 - $310,189	-3,172 Reduced 7.57%	38,721 $2.95 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $38,517 - $48,193	534 Added 1.29%	41,893 $3.71 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $18,579 - $22,337	-295 Reduced 0.71%	41,359 $3.13 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $71,613 - $91,538	-1,090 Reduced 2.55%	41,654 $3.03 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $17.4 Million - $20.4 Million	-225,193 Reduced 84.05%	42,744 $3.45 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $339,114 - $418,219	-4,356 Reduced 1.6%	267,937 $24.7 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $329,144 - $365,905	-3,702 Reduced 1.34%	272,293 $25.8 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $489,211 - $578,847	5,449 Added 2.01%	275,995 $25.6 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $221,744 - $296,936	2,410 Added 0.9%	270,546 $25.6 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $844,998 - $926,611	-9,435 Reduced 3.4%	268,136 $25.9 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $19.4 Million - $24.8 Million	277,571	277,571 $24.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Abb Vie Inc. Transaction History